About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Kachestvennaya Klinicheskaya Praktika
›
top-articles
Kachestvennaya Klinicheskaya Praktika
0.3
(top 100%)
impact factor
124
(top 100%)
papers
123
(top 50%)
citations
5
(top 50%)
h
-index
0.4
(top 100%)
impact factor
152
all documents
129
doc citations
7
(top 100%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Socio-economic burden of COVID-19 in the Russian Federation
Kachestvennaya Klinicheskaya Praktika
2020
7
2
Socioeconomic and global burden of COVID-19
Kachestvennaya Klinicheskaya Praktika
2021
6
3
Review of real-world data study
Kachestvennaya Klinicheskaya Praktika
2021
6
4
Influence of dupilumab on the economic burden of severe asthma and atopic dermatitis
Kachestvennaya Klinicheskaya Praktika
2020
6
5
Use of unlicensed drugs and off-label drug use: focus on COVID-19
Kachestvennaya Klinicheskaya Praktika
2020
5
6
Pragmatic clinical trials
Kachestvennaya Klinicheskaya Praktika
2020
4
7
Risks associated with the ethical aspects of conducting clinical trials
Kachestvennaya Klinicheskaya Praktika
2020
4
8
Oral anticoagulants in the prevention of thromboembolic complications in cardiac patients: analysis of use in the Russian Federation
Kachestvennaya Klinicheskaya Praktika
2020
4
9
The pharmacoeconomic comparison of the fixed insulin glargine and lixisenatide combination with insulin degludec family in type 2 diabetes mellitus
Kachestvennaya Klinicheskaya Praktika
2021
3
10
Drug-induced liver damage with cholestasis
Kachestvennaya Klinicheskaya Praktika
2020
3
11
Is it possible to use riamilovir to prevent infection and treat COVID-19?
Kachestvennaya Klinicheskaya Praktika
2020
3
12
Current and future use of favipiravir in patients with COVID-19
Kachestvennaya Klinicheskaya Praktika
2020
3
13
Monitoring of safety using favipiravir: risk management of adverse drug reactions in clinical practice
Kachestvennaya Klinicheskaya Praktika
2020
3
14
Possibility to use direct oral anticoagulants to prevent thromboembolic events in patients with COVID-19
Kachestvennaya Klinicheskaya Praktika
2020
3
15
Rationality of routine clinical use of olokizumab in COVID-19
Kachestvennaya Klinicheskaya Praktika
2020
3
16
Analysis of the effectiveness of vaccination against COVID-19 based on real-world data in St. Petersburg
Kachestvennaya Klinicheskaya Praktika
2022
3
17
Lifestyle Changes in Medical Students during the COVID-19 Pandemic
Kachestvennaya Klinicheskaya Praktika
2022
3
18
Resource consumption and patient employability during systemic therapy and biological therapy
Kachestvennaya Klinicheskaya Praktika
2021
2
19
Applying real-world data to support regulatory decision — making in the United States
Kachestvennaya Klinicheskaya Praktika
2021
2
20
Ethical aspects of using software with artificial intelligence technology
Kachestvennaya Klinicheskaya Praktika
2021
2
21
Pharmacoeconomic analysis of the choice of antimicrobial drugs for the treatment of community-acquired pneumonia by physicians and final year medical students
Kachestvennaya Klinicheskaya Praktika
2021
2
22
Current aspects of risk management in clinical trials
Kachestvennaya Klinicheskaya Praktika
2020
2
23
Possibility to use barycytinib in patients with COVID-19, including for treatment of «cytokine storm»
Kachestvennaya Klinicheskaya Praktika
2020
2
24
Current and future use of colchicine in patients with COVID-19
Kachestvennaya Klinicheskaya Praktika
2020
2
25
Multivariate analysis of medication adherence among outpatients with stable coronary artery disease
Kachestvennaya Klinicheskaya Praktika
2022
2
26
Nonsteroidal anti-inflammatory drugs’ adverse drug reactions: 10 years of national database data
Kachestvennaya Klinicheskaya Praktika
2022
2
27
A logistic regression-based model to predict ICU mortality: problems and solutions
Kachestvennaya Klinicheskaya Praktika
2022
2
28
Comparative pharmacoeconomic analysis of the use of apixaban, rivaroxaban and dabigatran for prevention of stroke and embolism in the vessels of the systemic circulation in patients with non-valvular atrial fibrillation
Kachestvennaya Klinicheskaya Praktika
2023
2
29
Effect of medication adherence on the risk of cardiovascular events in outpatients with stable coronary artery disease: results of two-year monitoring
Kachestvennaya Klinicheskaya Praktika
2023
2
30
Palliative care organization in the light of updated legislation
Kachestvennaya Klinicheskaya Praktika
2021
1
31
Th e clinical-economic analysis of Dupilumab in severe asthma
Kachestvennaya Klinicheskaya Praktika
2021
1
32
Cystic fibrosis as a social-economic burden
Kachestvennaya Klinicheskaya Praktika
2021
1
33
Legal aspects of conducting real-world studies
Kachestvennaya Klinicheskaya Praktika
2021
1
34
Pharmacoeconomic feasibility of using Mirabegron in patients with overactive bladder
Kachestvennaya Klinicheskaya Praktika
2021
1
35
Pharmacoeconomic comparison of the second generation insulin analogs and insulins on their base
Kachestvennaya Klinicheskaya Praktika
2021
1
36
COVID-19: economic aspects of influenza vaccine prevention
Kachestvennaya Klinicheskaya Praktika
2021
1
37
Ethical aspects of the Internet of Bodies
Kachestvennaya Klinicheskaya Praktika
2021
1
38
Pharmacoeconomic comparison of insulin glargine and insulin detemir in diabetes mellitus type 2
Kachestvennaya Klinicheskaya Praktika
2020
1
39
Health-economic analysis of tocilizumab in patients with rheumatoid arthritis and systemic juvenile arthritis
Kachestvennaya Klinicheskaya Praktika
2020
1
40
Review of the European standard for postgraduate training of medical specialists in internal medicine and prospects for implementation in Russian Federation
Kachestvennaya Klinicheskaya Praktika
2020
1
41
Pharmacoeconomic analysis of atezolizumab plus nab-paclitaxel in the treatment of the advanced or metastatic triple-negative breast cancer
Kachestvennaya Klinicheskaya Praktika
2020
1
42
Clinical Pharmacology in Health Care, Teaching and Research
Kachestvennaya Klinicheskaya Praktika
2020
1
43
Analysis of the long-term effectiveness of a drug in the treatment of a chronic disease is the basis of rational pharmacotherapy (on the example of the use of roflumilast in the treatment of chronic obstructive pulmonary disease)
Kachestvennaya Klinicheskaya Praktika
2020
1
44
Implementation of the concept of standard operating procedures into primary care practice: utopia or urgent need?
Kachestvennaya Klinicheskaya Praktika
2020
1
45
Methylprednisolone in acute respiratory distress-syndrome in COVID-19: rationales for use, optimal dosage regimens, combined use with tocilizumab
Kachestvennaya Klinicheskaya Praktika
2020
1
46
What are the indications for combined use of hydroxychloroquine and lopinavir/ritonavir, and how should treatment safety monitoring be performed?
Kachestvennaya Klinicheskaya Praktika
2020
1
47
Current and future use of umifenovir in patients with COVID-19
Kachestvennaya Klinicheskaya Praktika
2020
1
48
Change of opinion on the use of hydroxychloroquine for COVID-19 treatment and prevention
Kachestvennaya Klinicheskaya Praktika
2020
1
49
Current and future use of dipyridamole in patients with COVID-19
Kachestvennaya Klinicheskaya Praktika
2020
1
50
Analysis of the effectiveness of the use of financial resources in the procurement of pharmaceuticals for state needs
Kachestvennaya Klinicheskaya Praktika
2022
1
site/software ©
exaly
; All materials licenced under
CC by-SA
.